Health BridgeBio Pharma and Helsinn Group Announce Strategic Collaboration to Co-Develop and… James Pereira Nov 19, 2021 - The potentially first-in-class inhibitor designed to target glutathione peroxidase 4 (GPX4) has the potential to… Read More...
